Sheng Han Selected Research

Sheng Han Research Topics

Disease

25	Neoplasms (Cancer) 10/2023 - 12/2013
14	Glioma (Gliomas) 10/2023 - 01/2013
9	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 09/2014
9	Glioblastoma (Glioblastoma Multiforme) 03/2022 - 01/2013
4	Coronary Disease (Coronary Heart Disease) 02/2024 - 01/2018
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
3	Infections 03/2024 - 01/2015
3	Inflammation (Inflammations) 03/2023 - 01/2021
3	Carcinogenesis 10/2017 - 02/2015
2	Reperfusion Injury 09/2023 - 01/2023
2	Hypoxia (Hypoxemia) 09/2023 - 01/2014
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2023 - 01/2017
2	Ischemic Stroke 06/2022 - 01/2022
2	Stroke (Strokes) 06/2022 - 12/2021
2	Hypersensitivity (Allergy) 01/2022 - 11/2014
2	Ischemia 01/2021 - 01/2021
2	Asthma (Bronchial Asthma) 04/2018 - 10/2015
2	Burns 04/2004 - 09/2003
1	Essential Hypertension 03/2024
1	Human Influenza (Influenza) 02/2024
1	Fatigue 02/2024
1	Weight Loss (Weight Reduction) 02/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Meningioma (Meningiomas) 11/2022
1	Brain Edema (Cerebral Edema) 11/2022
1	Dyspepsia (Indigestion) 09/2022
1	Pica (Geophagia) 06/2022
1	Angina Pectoris 03/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Vertigo (Positional Vertigo) 01/2022
1	Cerebral Infarction 01/2022
1	Cholangiocarcinoma 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 03/2023 - 09/2003
4	MicroRNAs (MicroRNA)IBA 01/2020 - 10/2015
3	Transcription Factors (Transcription Factor)IBA 10/2023 - 02/2015
3	Temozolomide (Temodar)FDA LinkGeneric 03/2022 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2017
3	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 02/2014
3	Messenger RNA (mRNA)IBA 08/2015 - 01/2013
3	p38 Mitogen-Activated Protein KinasesIBA 12/2014 - 09/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2015
2	Hormones (Hormone)IBA 01/2023 - 01/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2017
2	LithiumIBA 03/2022 - 05/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
2	Circular RNAIBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2017
2	danhongIBA 12/2021 - 01/2020
2	InflammasomesIBA 01/2021 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2018
2	salvianolateIBA 01/2020 - 01/2018
2	alectinibIBA 01/2020 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2018 - 10/2015
2	Phosphotransferases (Kinase)IBA 09/2014 - 09/2003
2	SB 203580IBA 04/2004 - 09/2003
2	salicylhydroxamic acid (SHAM)IBA 04/2004 - 09/2003
1	Antihypertensive Agents (Antihypertensives)IBA 03/2024
1	shexiang tongxinIBA 02/2024
1	Tacrolimus Binding Protein 1A (FKBP12)IBA 10/2023
1	Histones (Histone)IBA 09/2023
1	ethylene ureaIBA 02/2023
1	CopperIBA 02/2023
1	AllantoinIBA 02/2023
1	bailing capsulesIBA 01/2023
1	serum-glucocorticoid regulated kinaseIBA 01/2023
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2023
1	LigandsIBA 01/2023
1	semaglutideIBA 01/2023
1	polyethylene glycol loxenatideIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	ORALIT (ORS)IBA 11/2022
1	B7-H1 AntigenIBA 11/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2022
1	mosaprideIBA 09/2022
1	Butyric Acid (Butanoic Acid)IBA 06/2022
1	MDMB-4en-PINACAIBA 06/2022
1	QilongIBA 06/2022
1	guanxin shutongIBA 03/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	gastrodinIBA 01/2022
1	Ribavirin (Virazole)FDA LinkGeneric 01/2022
1	EdaravoneIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Sulbactam FDA LinkGeneric 01/2022

Therapy/Procedure

12	Therapeutics 01/2023 - 12/2014
6	Drug Therapy (Chemotherapy) 01/2023 - 01/2013
3	Liver Transplantation 09/2023 - 01/2021
2	Length of Stay 03/2024 - 01/2018
2	Warm Ischemia 09/2023 - 01/2023
2	Radiotherapy 11/2022 - 01/2014
1	Immunotherapy 09/2023
1	Aftercare (After-Treatment) 06/2022
1	Injections 01/2022